TY  - BOOK
AU  - Jones,Bleddyn
AU  - Moore,Joshua
ED  - Institute of Physics (Great Britain),
TI  - Quantitative radiobiology for proton therapy
T2  - [IOP release $release]
SN  - 9780750362092
AV  - RC271.R3 J667 2024eb
PY  - 2024///]
CY  - Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK)
PB  - IOP Publishing
KW  - Radiobiology
KW  - Radiotherapy
KW  - Protons
KW  - Therapeutic use
KW  - methods
KW  - Proton Therapy
KW  - Pre-clinical medicine - basic sciences
KW  - bicssc
KW  - MEDICAL / Radiology, Radiotherapy & Nuclear Medicine
KW  - bisacsh
N1  - Revised edition of: Practical radiobiology for proton therapy planning; "Version: 20240701"--Title page verso; Includes bibliographical references; 1. Particle physics for biological interactions -- 1.1. Physical beam parameters, essential dosimetry and reference (or control) radiation requirements for RBE studies -- 1.2. Physics interacting with biology; 2. The essential radiobiology background -- 2.1. Introduction -- 2.2. Background and models -- 2.3. The [alpha]/[beta] ratio and its choice for modelling particle therapies -- 2.4. The design of experiments for RBE determination and other purposes; 3. Medical and surgical considerations that influence radiation tolerances, including interpretation of clinical trials -- 3.1. Introduction -- 3.2. Surgery -- 3.3. Cytotoxic chemotherapies -- 3.4. Age and other medical conditions -- 3.5. Reductions in prescribed dose -- 3.6. Interpretation of the case histories and literature -- 3.7. Clinical trials -- 3.8. Ethical issues -- 3.9. Mixed end points -- 3.10. The importance of follow-up -- 3.11. Publication bias; 4. Treatment planning and further medical perspectives -- 4.1. Introduction; 5. Historical development of radiotherapy : what was learned from fast neutrons including their linkage with proton relative biological effect -- 5.1. Introduction -- 5.2. A brief synopsis -- 5.3. Neutron therapy -- 5.4. More recent developments based on neutron studies -- 5.5. Estimation of neutron RBE from neutron energy -- 5.6. Some important conclusions; 6. Fractionation modelling -- 6.1. Introduction and background radiobiology -- 6.2. A brief history of fractionation -- 6.3. Modelling of fractionation -- 6.4. The use of the linear quadratic model with large fraction sizes -- 6.5. Optimisation of fractionation using calculus methods -- 6.6. Other contributions to fractionation -- 6.7. Summary; 7. The scientific case for using a variable proton RBE rather than a constant RBE -- 7.1. Introduction -- 7.2. Discussion; 8. A general RBE linear energy-efficiency model for protons and light ions -- 8.1. Introduction -- 8.2. The available experimental data and its important limitations -- 8.3. Description of the Z-specific model -- 8.4. The graphical results -- 8.5. Further investigations : properties of LETU -- 8.6. Conclusions and what remains to be done; 9. Inclusion of the energy-efficiency LET and RBE model in proton therapy -- 9.1. Introduction -- 9.2. RBE uncertainties -- 9.3. Description of the quantitative model -- 9.4. RBE graphical examples -- 9.5. Some comparisons with experimental data sets -- 9.6. Two clinical examples where PBT could be sub-optimal -- 9.7. Prediction of tumour response from the RBE increment -- 9.8. Intensification of dose rates -- 9.9. Concluding discussion; 10. Proton therapy risk assessment using small increments in RBE in the central nervous system and estimation of remission times -- 10.1. Introduction -- 10.2. Methods -- 10.3. Results -- 10.4. Discussion -- 10.5. Conclusions; 11. Radiobiological interpretation of the finding of RBE changes within similar SOBPs placed at superficial and deep locations in passively scattered beams but not in scanned pencil beams -- 11.1. Introduction -- 11.2. Methods -- 11.3. Results -- 11.4. Discussion -- 11.5. Conclusions; 12. Particle therapy dose-time compensations in unintended interruptions and re-treatments -- 12.1. Introduction -- 12.2. Unintended treatment interruptions -- 12.3. Re-treatments; 13. Errors of Bragg peak positioning and their radio-biological correction -- 13.1. Introduction -- 13.2. Model description -- 13.3. Conclusions; 14. What remains to be done : including FLASH dose rates and conclusions -- 14.1. Introduction -- 14.2. Dose escalation where circumstances permit -- 14.3. Simultaneous 'sensitisation' effects by new therapies -- 14.4. Sensitivity analysis of the energy-efficiency model -- 14.5. What could be achieved in a single international laboratory dedicated to high-LET radiobiology -- 14.6. Some untested situations -- 14.7. Conclusions; Full-text restricted to subscribers or individual document purchasers; Medical engineering, biomedical engineers, clinicians specializing in proton therapy and radiotherapy and radiobiology. Proton therapy centers and large regional cancer centers; Also available in print
N2  - This book is an extension and major update of the author's previous work, titled Practical Radiobiology for Proton Therapy Planning (IOP Publishing 2018). The book describes the relative biological effectiveness (RBE) issues within proton therapy and advises on how to use a variable RBE within treatment planning and in dose prescription to improve the safety of proton and other forms on ion beam therapy. Decision-making advice is also provided for protocol breaches, retreatments, dose rate effects and risk assessment. This book is intended for those who already have basic knowledge of radiotherapy and radiobiology, although there is guidance through the fundamental principles for those who are 'discipline crossing'. Part of IPEM-IOP Series in Physics and Engineering in Medicine and Biology
UR  - https://iopscience.iop.org/book/mono/978-0-7503-6209-2
ER  -